Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.
Ataxia
Cerebellum
GM2 gangliosidosis
Late-onset Tay–Sachs disease
Proximal weakness of lower extremities
β-Hexosaminidase A
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
02
12
2018
accepted:
06
05
2019
revised:
02
05
2019
pubmed:
12
5
2019
medline:
10
1
2020
entrez:
12
5
2019
Statut:
ppublish
Résumé
Tay-Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal β-hexosaminidase A deficiency due to mutations in the HEXA gene. The late-onset form of disease (LOTS) is considered rare, and only a limited number of cases have been reported. The clinical course of LOTS differs substantially from classic infantile TSD. Comprehensive data from 14 Czech patients with LOTS were collated, including results of enzyme assays and genetic analyses. 14 patients (9 females, 5 males) with LOTS were diagnosed between 2002 and 2018 in the Czech Republic (a calculated birth prevalence of 1 per 325,175 live births). The median age of first symptoms was 21 years (range 10-33 years), and the median diagnostic delay was 10.5 years (range 0-29 years). The main clinical symptoms at the time of manifestation were stammering or slurred speech, proximal weakness of the lower extremities due to anterior horn cell neuronopathy, signs of neo- and paleocerebellar dysfunction and/or psychiatric disorders. Cerebellar atrophy detected through brain MRI was a common finding. Residual enzyme activity was 1.8-4.1% of controls. All patients carried the typical LOTS-associated c.805G>A (p.Gly269Ser) mutation on at least one allele, while a novel point mutation, c.754C>T (p.Arg252Cys) was found in two siblings. LOTS seems to be an underdiagnosed cause of progressive distal motor neuron disease, with variably expressed cerebellar impairment and psychiatric symptomatology in our group of adolescent and adult patients. The enzyme assay of β-hexosaminidase A in serum/plasma is a rapid and reliable tool to verify clinical suspicions.
Sections du résumé
BACKGROUND
BACKGROUND
Tay-Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal β-hexosaminidase A deficiency due to mutations in the HEXA gene. The late-onset form of disease (LOTS) is considered rare, and only a limited number of cases have been reported. The clinical course of LOTS differs substantially from classic infantile TSD.
METHODS
METHODS
Comprehensive data from 14 Czech patients with LOTS were collated, including results of enzyme assays and genetic analyses.
RESULTS
RESULTS
14 patients (9 females, 5 males) with LOTS were diagnosed between 2002 and 2018 in the Czech Republic (a calculated birth prevalence of 1 per 325,175 live births). The median age of first symptoms was 21 years (range 10-33 years), and the median diagnostic delay was 10.5 years (range 0-29 years). The main clinical symptoms at the time of manifestation were stammering or slurred speech, proximal weakness of the lower extremities due to anterior horn cell neuronopathy, signs of neo- and paleocerebellar dysfunction and/or psychiatric disorders. Cerebellar atrophy detected through brain MRI was a common finding. Residual enzyme activity was 1.8-4.1% of controls. All patients carried the typical LOTS-associated c.805G>A (p.Gly269Ser) mutation on at least one allele, while a novel point mutation, c.754C>T (p.Arg252Cys) was found in two siblings.
CONCLUSION
CONCLUSIONS
LOTS seems to be an underdiagnosed cause of progressive distal motor neuron disease, with variably expressed cerebellar impairment and psychiatric symptomatology in our group of adolescent and adult patients. The enzyme assay of β-hexosaminidase A in serum/plasma is a rapid and reliable tool to verify clinical suspicions.
Identifiants
pubmed: 31076878
doi: 10.1007/s00415-019-09364-3
pii: 10.1007/s00415-019-09364-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1953-1959Subventions
Organisme : Univerzita Karlova v Praze
ID : UNCE 204064
Organisme : Univerzita Karlova v Praze
ID : PROGRES Q26/LF1
Organisme : Ministerstvo Zdravotnictví Ceské Republiky (CZ)
ID : RVO-VFN 64165/2012
Références
Eur J Pediatr. 2000 Dec;159 Suppl 3:S192-5
pubmed: 11216898
Isr Med Assoc J. 2004 Feb;6(2):107-11
pubmed: 14986470
Genet Med. 2005 Feb;7(2):119-23
pubmed: 15714079
Genet Med. 2009 Jun;11(6):425-33
pubmed: 19346952
Hum Mutat. 2010 Nov;31(11):1240-50
pubmed: 20672374
Surv Ophthalmol. 2014 Jan-Feb;59(1):64-76
pubmed: 24011710
Science. 1989 Mar 17;243(4897):1471-4
pubmed: 2522679
Orphanet J Rare Dis. 2015 Apr 17;10:45
pubmed: 25896637
Br J Psychiatry. 1989 Sep;155:410-3
pubmed: 2611559
BMJ Case Rep. 2016 Mar 31;2016:
pubmed: 27033294
Pract Neurol. 2017 Oct;17(5):396-399
pubmed: 28739864
JIMD Rep. 2018;41:17-23
pubmed: 29214523
Am J Med Genet. 1986 May;24(1):179-96
pubmed: 2939718
Neurology. 1979 Jun;29(6):848-54
pubmed: 572006
JAMA. 1993 Nov 17;270(19):2307-15
pubmed: 8230592
J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):10-9
pubmed: 9547461